General Information of the Protein
Protein ID
PT03566
Protein Name
Solute carrier organic anion transporter family member 1B1
Secondarily
Protein Name
Liver-specific organic anion transporter 1
OATP-C
Organic anion transporter SLC21A6
Sodium-independent organic anion-transporting polypeptide 2
Solute carrier family 21 member 6
Gene Name
SLCO1B1
Secondarily
Gene Name
LST1
OATP1B1
OATP2
OATPC
SLC21A6
Sequence
MDQNQHLNKTAEAQPSENKKTRYCNGLKMFLAALSLSFIAKTLGAIIMKSSIIHIERRFEISSSLVGFIDGSFEIGNLLVIVFVSYFGSKLHRPKLIGIGCFIMGIGGVLTALPHFFMGYYRYSKETNINSSENSTSTLSTCLINQILSLNRASPEIVGKGCLKESGSYMWIYVFMGNMLRGIGETPIVPLGLSYIDDFAKEGHSSLYLGILNAIAMIGPIIGFTLGSLFSKMYVDIGYVDLSTIRITPTDSRWVGAWWLNFLVSGLFSIISSIPFFFLPQTPNKPQKERKASLSLHVLETNDEKDQTANLTNQGKNITKNVTGFFQSFKSILTNPLYVMFVLLTLLQVSSYIGAFTYVFKYVEQQYGQPSSKANILLGVITIPIFASGMFLGGYIIKKFKLNTVGIAKFSCFTAVMSLSFYLLYFFILCENKSVAGLTMTYDGNNPVTSHRDVPLSYCNSDCNCDESQWEPVCGNNGITYISPCLAGCKSSSGNKKPIVFYNCSCLEVTGLQNRNYSAHLGECPRDDACTRKFYFFVAIQVLNLFFSALGGTSHVMLIVKIVQPELKSLALGFHSMVIRALGGILAPIYFGALIDTTCIKWSTNNCGTRGSCRTYNSTSFSRVYLGLSSMLRVSSLVLYIILIYAMKKKYQEKDINASENGSVMDEANLESLNKNKHFVPSAGADSETHC
    Show/Hide
Organism
Homo sapiens, Human
Protein Classification
Transporter
>
Electrochemical transporter
>
SLC superfamily of solute carriers
>
SLC21/SLCO family of organic anion transporting polypeptides
Function
Mediates the Na(+)-independent uptake of organic anions (PubMed:10358072, PubMed:15159445, PubMed:17412826). Shows broad substrate specificity, can transport both organic anions such as bile acid taurocholate (cholyltaurine) and conjugated steroids (dehydroepiandrosterone 3-sulfate, 17-beta-glucuronosyl estradiol, and estrone 3-sulfate), as well as eicosanoids (prostaglandin E2, thromboxane B2, leukotriene C4, and leukotriene E4), and thyroid hormones (T4/L-thyroxine, and T3/3,3',5'-triiodo-L-thyronine) (PubMed:10358072, PubMed:10601278, PubMed:10873595, PubMed:12568656, PubMed:15159445, PubMed:15970799, PubMed:16627748, PubMed:17412826, PubMed:12196548, PubMed:11159893, PubMed:19129463, PubMed:26979622). Can take up bilirubin glucuronides from plasma into the liver, contributing to the detoxification-enhancing liver-blood shuttling loop (PubMed:22232210). Involved in the clearance of endogenous and exogenous substrates from the liver (PubMed:10358072, PubMed:10601278). Transports coproporphyrin I and III, by-products of heme synthesis, and may be involved in their hepatic disposition (PubMed:26383540). May contribute to regulate the transport of organic compounds in testes across the blood-testis-barrier (Probable). Can transport HMG-CoA reductase inhibitors (also known as statins), such as pravastatin and pitavastatin, a clinically important class of hypolipidemic drugs (PubMed:10601278, PubMed:15970799, PubMed:15159445). May play an important role in plasma and tissue distribution of the structurally diverse chemotherapeutic drug methotrexate (PubMed:23243220). May also transport antihypertension agents, such as the angiotensin-converting enzyme (ACE) inhibitor prodrug enalapril, and the highly selective angiotensin II AT1-receptor antagonist valsartan, in the liver (PubMed:16627748, PubMed:16624871). Shows a pH-sensitive substrate specificity towards prostaglandin E2 and T4 which may be ascribed to the protonation state of the binding site and leads to a stimulation of substrate transport in an acidic microenvironment (PubMed:19129463). Hydrogencarbonate/HCO3(-) acts as the probable counteranion that exchanges for organic anions (PubMed:19129463).
    Show/Hide
Uniprot ID
Primary ID:
Q9Y6L6

Secondarily ID:
B2R7G2
Q29R64
Q9NQ37
Q9UBF3
Q9UH89
    Show/Hide
Ensembl ID
ENSG00000134538
HGNC ID
HGNC:10959
Subcellular Location
Basolateral cell membrane
Basal cell membrane
Map of Molecular Bioactivity Related to the Protein
Map of Molecular Bioactivity Related to the Protein

Protein
Cell Line
Compound

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Protein
Cell Line ID: CL000011 , CHO
Compound ID Compound Name Compound Formula
CP0161979
methyl 8,10-dichloro-9-hydroxy-3-methoxy-1,7-dimethyl-6-oxobenzo[b][1,4]benzodioxepine-2-carboxylate
   Show/Hide
C18H14Cl2O7
 2
1
IC50 = 102.33 nM
   TI
   LI
   LO
   TS
2
Ki = 60 nM
   TI
   LI
   LO
   TS
CP0083586
methyl 8,10-dichloro-3,9-dihydroxy-1,4,7-trimethyl-6-oxobenzo[b][1,4]benzodioxepine-2-carboxylate
   Show/Hide
C18H14Cl2O7
 2
1
IC50 = 144.54 nM
   TI
   LI
   LO
   TS
2
Ki = 80 nM
   TI
   LI
   LO
   TS
CP0182760
Sarsasapogenin
   Show/Hide
C27H44O3
 2
1
IC50 = 245.47 nM
   TI
   LI
   LO
   TS
2
Ki = 130 nM
   TI
   LI
   LO
   TS
CP0043276
CAS_114798-26-4
   Show/Hide
C22H23ClN6O
 2
1
IC50 = 288.4 nM
   TI
   LI
   LO
   TS
2
Ki = 160 nM
   TI
   LI
   LO
   TS
CP0077816
LASALOCID A SODIUM
   Show/Hide
C34H53NaO8
 2
1
IC50 = 478.63 nM
   TI
   LI
   LO
   TS
2
Ki = 260 nM
   TI
   LI
   LO
   TS
CP0052039
18beta-glycyrrhetic acid
   Show/Hide
C30H46O4
 2
1
IC50 = 524.81 nM
   TI
   LI
   LO
   TS
2
Ki = 290 nM
   TI
   LI
   LO
   TS
CP0018902
(5Z,8Z,11Z,14Z)-icosa-5,8,11,14-tetraenoic acid
   Show/Hide
C20H32O2
 2
1
IC50 = 602.56 nM
   TI
   LI
   LO
   TS
2
Ki = 330 nM
   TI
   LI
   LO
   TS
CP0355438
BETA CAROTENE
   Show/Hide
C40H56
 2
1
IC50 = 616.6 nM
   TI
   LI
   LO
   TS
2
Ki = 340 nM
   TI
   LI
   LO
   TS
CP0379894
BRL-1702
   Show/Hide
C19H18Cl2N3NaO6S
 2
1
IC50 = 676.08 nM
   TI
   LI
   LO
   TS
2
Ki = 370 nM
   TI
   LI
   LO
   TS
CP0391465
[(1R,2R,7S,8R,9S,17S,18S,20R,22S)-8-acetyloxy-17-(furan-3-yl)-3,7-dihydroxy-22-(2-methoxy-2-oxoethyl)-2,5,11,18-tetramethyl-20-(2-methylbutanoyloxy)-15-oxo-10,12,16,21-tetraoxaheptacyclo[9.9.1.12,5.01,9.03,7.09,13.013,18]docosan-6-yl] 2,3-dimethyloxirane-2-carboxylate
   Show/Hide
C41H52O17
 2
1
IC50 = 676.08 nM
   TI
   LI
   LO
   TS
2
Ki = 380 nM
   TI
   LI
   LO
   TS
CP0870363
BUSSEIN
   Show/Hide
C43H54O18
 2
1
IC50 = 691.83 nM
   TI
   LI
   LO
   TS
2
Ki = 380 nM
   TI
   LI
   LO
   TS
CP0024953
2-Ethoxy-3-[2'-(1H-tetrazol-5-yl)-biphenyl-4-ylmethyl]-3H-benzoimidazole-4-carboxylic acid 1-cyclohexyloxycarbonyloxy-ethyl ester
   Show/Hide
C33H34N6O6
 2
1
IC50 = 724.44 nM
   TI
   LI
   LO
   TS
2
Ki = 400 nM
   TI
   LI
   LO
   TS
CP0027182
3-hydroxy-9-methoxy-6-oxo-7-pentanoyl-1-pentylbenzo[b][1,4]benzodioxepine-2-carboxylic acid
   Show/Hide
C25H28O8
 2
1
IC50 = 724.44 nM
   TI
   LI
   LO
   TS
2
Ki = 400 nM
   TI
   LI
   LO
   TS
CP0423174
[(1R,3Z,6S,7R,9R,10R,15R,16S,19S,20S)-18-acetyloxy-6-(furan-3-yl)-9,19,20-trimethoxy-3-(1-methoxy-2-methylpropylidene)-16-(2-methoxy-2-oxoethyl)-7,12,15,17-tetramethyl-4-oxo-5,11,13,21-tetraoxaheptacyclo[10.8.1.114,17.01,10.02,7.010,15.014,19]docosan-8-yl] 2-methylpropanoate
   Show/Hide
C43H58O16
 2
1
IC50 = 758.58 nM
   TI
   LI
   LO
   TS
2
Ki = 420 nM
   TI
   LI
   LO
   TS
CP0053690
(3S,6S,9S,12R,15S,18S,21S,24S,27R,30S,33S)-25,30-diethyl-33-((1R,2R)-1-hydroxy-2-methylhex-4-enyl)-6,9,18-triisobutyl-3,21,24-triisopropyl-1,4,7,10,12,15,19,27,28-nonamethyl-1,4,7,10,13,16,19,22,25,28,31-undecaazacyclotritriacontan-2,5,8,11,14,17,20,23,26,29,32-undecaone
   Show/Hide
C63H113N11O12
 1
1
IC50 = 800 nM
   TI
   LI
   LO
   TS
CP0391204
Atorvastatin
   Show/Hide
C66H68CaF2N4O10
 2
1
IC50 = 812.83 nM
   TI
   LI
   LO
   TS
2
Ki = 450 nM
   TI
   LI
   LO
   TS
CP0433032
[(1S,4bS,5R,6aS,8R,10aR,10bS,12aS)-5-acetyloxy-1-(furan-3-yl)-4b,7,7,10a,12a-pentamethyl-3-oxo-1,5,6,6a,8,9,10,10b,11,12-decahydronaphtho[2,1-f]isochromen-8-yl] acetate
   Show/Hide
C30H40O7
 2
1
IC50 = 812.83 nM
   TI
   LI
   LO
   TS
2
Ki = 440 nM
   TI
   LI
   LO
   TS
CP0650250
SID855631
   Show/Hide
C44H43ClN2O8
 2
1
IC50 = 812.83 nM
   TI
   LI
   LO
   TS
2
Ki = 450 nM
   TI
   LI
   LO
   TS
CP0514201
[(1S,2R,4S,7S,8S,10R,11R,12S,13S,15R,17S,19R)-10,13,15-triacetyloxy-7-(furan-3-yl)-1,8,12,16,16-pentamethyl-5-oxo-3,6-dioxapentacyclo[9.8.0.02,4.02,8.012,17]nonadecan-19-yl] acetate
   Show/Hide
C34H44O12
 2
1
IC50 = 870.96 nM
   TI
   LI
   LO
   TS
2
Ki = 480 nM
   TI
   LI
   LO
   TS
CP0391201
methyl 2-[(1S,3S,5S,7S,8S,9R,12S,13S)-5-acetyloxy-13-(furan-3-yl)-6,6,8,12-tetramethyl-17-methylidene-15-oxo-2,14-dioxatetracyclo[7.7.1.01,12.03,8]heptadecan-7-yl]acetate
   Show/Hide
C29H38O8
 2
1
IC50 = 933.25 nM
   TI
   LI
   LO
   TS
2
Ki = 510 nM
   TI
   LI
   LO
   TS
CP0071410
Benicar
   Show/Hide
C29H30N6O6
 2
1
IC50 = 977.24 nM
   TI
   LI
   LO
   TS
2
Ki = 540 nM
   TI
   LI
   LO
   TS
CP0381198
[(1R,2R,4S,7R,8R,11R,12S,13S,15R,17S,19R)-13-acetyloxy-7-(furan-3-yl)-19-hydroxy-1,8,12,16,16-pentamethyl-5-oxo-3,6-dioxapentacyclo[9.8.0.02,4.02,8.012,17]nonadecan-15-yl] acetate
   Show/Hide
C30H40O9
 2
1
IC50 = 977.24 nM
   TI
   LI
   LO
   TS
2
Ki = 540 nM
   TI
   LI
   LO
   TS
CP0053689
(3R)-3-[(2S,5S,8S,11S,14R,17S,20S,23S,26S,29S,32R)-29-ethyl-26-[(E,1R,2R)-1-hydroxy-2-methylhex-4-enyl]-1,7,11,14,16,19,22,25,31,32-decamethyl-8,17,20-tris(2-methylpropyl)-3,6,9,12,15,18,21,24,27,30,33-undecaoxo-5,23-di(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacont-2-yl]butanenitrile
   Show/Hide
C63H110N12O12
 1
1
IC50 = 1000 nM
   TI
   LI
   LO
   TS
CP0051629
4-hydroxy-3-(4-hydroxyphenyl)-5-methoxy-8,8-dimethyl-6-(3-methylbut-2-enyl)pyrano[2,3-h]chromen-2-one
   Show/Hide
C26H26O6
 2
1
IC50 = 1071.52 nM
   TI
   LI
   LO
   TS
2
Ki = 590 nM
   TI
   LI
   LO
   TS
CP0166263
NORSTICTIC ACID
   Show/Hide
C18H12O9
 2
1
IC50 = 1148.15 nM
   TI
   LI
   LO
   TS
2
Ki = 630 nM
   TI
   LI
   LO
   TS
CP0283462
4-[12,18-dihydroxy-8,21,21-trimethyl-5-(3-methylbutyl)-8-(4-methylpentyl)-14-oxo-3,7,20-trioxahexacyclo[15.4.1.02,15.02,19.04,13.06,11]docosa-4(13),5,9,11-tetraen-19-yl]-2-methylbutanoic acid
   Show/Hide
C38H54O8
 2
1
IC50 = 1148.15 nM
   TI
   LI
   LO
   TS
2
Ki = 620 nM
   TI
   LI
   LO
   TS
CP0391198
(4R)-4-[(E)-3-carboxybut-2-enyl]-14-hydroxy-6,6,18-trimethyl-21-(3-methylbut-2-enyl)-18-(4-methylpent-3-enyl)-12-oxo-2,5,19-trioxapentacyclo[11.8.0.03,7.03,11.015,20]henicosa-1(13),10,14,16,20-pentaene-4-carboxylic acid
   Show/Hide
C38H46O9
 2
1
IC50 = 1174.9 nM
   TI
   LI
   LO
   TS
2
Ki = 650 nM
   TI
   LI
   LO
   TS
CP0113897
BILIRUBIN
   Show/Hide
C33H36N4O6
 2
1
IC50 = 1318.26 nM
   TI
   LI
   LO
   TS
2
Ki = 720 nM
   TI
   LI
   LO
   TS
CP0053688
(3S,6S,9S,12R,15S,18S,21S,24S,27R,30S,33S)-24-[(2R)-1-(3,3-difluoropyrrolidin-1-yl)propan-2-yl]-30-ethyl-33-[(E,1R,2R)-1-hydroxy-2-methylhex-4-enyl]-1,4,7,10,12,15,19,25,27,28-decamethyl-6,9,18-tris(2-methylpropyl)-3,21-di(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone
   Show/Hide
C66H116F2N12O12
 1
1
IC50 = 1400 nM
   TI
   LI
   LO
   TS
CP0198648
Beta-Escin
   Show/Hide
C54H84O24
 2
1
IC50 = 1412.54 nM
   TI
   LI
   LO
   TS
2
Ki = 780 nM
   TI
   LI
   LO
   TS
CP0433071
METHYL 6-ACETOXYANGOLENSATE
   Show/Hide
C29H36O9
 2
1
IC50 = 1445.44 nM
   TI
   LI
   LO
   TS
2
Ki = 800 nM
   TI
   LI
   LO
   TS
CP0435006
[(1S,4bS,5R,6aS,10aS,10bS,12aS)-1-(furan-3-yl)-4b,7,7,10a,12a-pentamethyl-3,8-dioxo-5,6,6a,10b,11,12-hexahydro-1H-naphtho[2,1-f]isochromen-5-yl] acetate
   Show/Hide
C28H34O6
 2
1
IC50 = 1513.56 nM
   TI
   LI
   LO
   TS
2
Ki = 830 nM
   TI
   LI
   LO
   TS
CP0426731
(1S,2R,4S,7S,8S,11R,12R,13R,15R,18R,20R)-7-(furan-3-yl)-20-hydroxy-1,8,12,17,17-pentamethyl-3,6,14-trioxahexacyclo[9.9.0.02,4.02,8.012,18.013,15]icosane-5,16-dione
   Show/Hide
C26H32O7
 1
1
IC50 = 1584.89 nM
   TI
   LI
   LO
   TS
CP0391194
beta-DIHYDROGEDUNOL
   Show/Hide
C28H38O7
 1
1
IC50 = 1698.24 nM
   TI
   LI
   LO
   TS
CP0198647
(3S,6S,9S,12R,15S,18S,21S,24S,27R,30S,33S)-30-ethyl-33-[(E,1R,2R)-1-hydroxy-2-methylhex-4-enyl]-1,4,7,10,12,15,19,25,27,28-decamethyl-6,9,18-tris(2-methylpropyl)-24-[(2R)-1-(8-oxa-3-azabicyclo[3.2.1]octan-3-yl)propan-2-yl]-3,21-di(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone
   Show/Hide
C68H120N12O13
 1
1
IC50 = 1800 nM
   TI
   LI
   LO
   TS
CP0412248
(3S,6S,9S,12R,15S,18S,21S,24S,27R,30S,33S)-30-ethyl-33-[(E,1R,2R)-1-hydroxy-2-methylhex-4-enyl]-1,4,7,10,12,15,19,25,27,28-decamethyl-6,9,18-tris(2-methylpropyl)-24-[(2R)-1-(1,4-oxazepan-4-yl)propan-2-yl]-3,21-di(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone
   Show/Hide
C67H120N12O13
 1
1
IC50 = 1800 nM
   TI
   LI
   LO
   TS
CP0083167
4'-((1,4'-dimethyl-2'-propyl(2,6'-bi-1H-benzimidazol)-1'-yl)methyl)-(1,1'-biphenyl)-2-carboxylic acid
   Show/Hide
C33H30N4O2
 2
1
IC50 = 1862.09 nM
   TI
   LI
   LO
   TS
2
Ki = 1030 nM
   TI
   LI
   LO
   TS
CP0053687
1-[(2R)-2-[(2S,5S,8S,11S,14R,17S,20S,23S,26S,29S,32R)-29-ethyl-26-[(E,1R,2R)-1-hydroxy-2-methylhex-4-enyl]-1,7,11,14,16,19,22,25,31,32-decamethyl-8,17,20-tris(2-methylpropyl)-3,6,9,12,15,18,21,24,27,30,33-undecaoxo-5,23-di(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacont-2-yl]propyl]piperidine-4-carbonitrile
   Show/Hide
C68H119N13O12
 1
1
IC50 = 1900 nM
   TI
   LI
   LO
   TS
CP0408703
CARBENOXOLONE DISODIUM
   Show/Hide
C34H48Na2O7
 2
1
IC50 = 1949.84 nM
   TI
   LI
   LO
   TS
2
Ki = 1070 nM
   TI
   LI
   LO
   TS
CP0381174
(Z)-4-[(1S,2S,8R,17S,19S)-12,18-dihydroxy-8,21,21-trimethyl-5-(3-methylbut-2-enyl)-8-(4-methylpent-3-enyl)-14-oxo-3,7,20-trioxahexacyclo[15.4.1.02,15.02,19.04,13.06,11]docosa-4(13),5,9,11-tetraen-19-yl]-2-methylbut-2-enoic acid
   Show/Hide
C38H48O8
 2
1
IC50 = 1995.26 nM
   TI
   LI
   LO
   TS
2
Ki = 1100 nM
   TI
   LI
   LO
   TS
CP0261565
(3S,6S,9S,12R,15S,18S,21S,24S,27R,30S,33S)-30-ethyl-33-[(E,1R,2R)-1-hydroxy-2-methylhex-4-enyl]-24-[(2R)-1-[2-methoxyethyl(methyl)amino]propan-2-yl]-1,4,7,10,12,15,19,25,27,28-decamethyl-6,9,18-tris(2-methylpropyl)-3,21-di(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone
   Show/Hide
C66H120N12O13
 1
1
IC50 = 2000 nM
   TI
   LI
   LO
   TS
CP0381175
[(1S,4bS,5R,6aS,8R,10aR,10bS,12aS)-1-(furan-3-yl)-8-hydroxy-4b,7,7,10a,12a-pentamethyl-3-oxo-1,5,6,6a,8,10b,11,12-octahydronaphtho[2,1-f]isochromen-5-yl] acetate
   Show/Hide
C28H36O6
 2
1
IC50 = 2187.76 nM
   TI
   LI
   LO
   TS
2
Ki = 1210 nM
   TI
   LI
   LO
   TS
CP0049972
RETINYL ACETATE
   Show/Hide
C22H32O2
 2
1
IC50 = 2238.72 nM
   TI
   LI
   LO
   TS
2
Ki = 1220 nM
   TI
   LI
   LO
   TS
CP0280690
(Z)-4-[12,18-dihydroxy-8,21,21-trimethyl-5-(3-methylbut-2-enyl)-8-(4-methylpent-3-enyl)-14-oxo-3,7,20-trioxahexacyclo[15.4.1.02,15.02,19.04,13.06,11]docosa-4(13),5,9,11,15-pentaen-19-yl]-2-methylbut-2-enoic acid
   Show/Hide
C38H46O8
 2
1
IC50 = 2238.72 nM
   TI
   LI
   LO
   TS
2
Ki = 1230 nM
   TI
   LI
   LO
   TS
CP0066372
methyl (Z)-4-[12-methoxy-8,21,21-trimethyl-5-(3-methylbut-2-enyl)-8-(4-methylpent-3-enyl)-14,18-dioxo-3,7,20-trioxahexacyclo[15.4.1.02,15.02,19.04,13.06,11]docosa-4,6(11),9,12,15-pentaen-19-yl]-2-methylbut-2-enoate
   Show/Hide
C40H48O8
 2
1
IC50 = 2290.87 nM
   TI
   LI
   LO
   TS
2
Ki = 1260 nM
   TI
   LI
   LO
   TS
CP0391202
PRIEURIANIN
   Show/Hide
C37H48O16
 2
1
IC50 = 2344.23 nM
   TI
   LI
   LO
   TS
2
Ki = 1280 nM
   TI
   LI
   LO
   TS
CP0381172
(1R,2R,4S,7S,8S,11R,12S,15S,17R)-7-(furan-3-yl)-15-hydroxy-1,8,12,16,16-pentamethyl-3,6-dioxapentacyclo[9.8.0.02,4.02,8.012,17]nonadec-13-ene-5,19-dione
   Show/Hide
C26H32O6
 2
1
IC50 = 2398.83 nM
   TI
   LI
   LO
   TS
2
Ki = 1330 nM
   TI
   LI
   LO
   TS
CP0042741
AURIN
   Show/Hide
C19H14O3
 2
1
IC50 = 2630.27 nM
   TI
   LI
   LO
   TS
2
Ki = 1430 nM
   TI
   LI
   LO
   TS
CP0070921
MLS001335996
   Show/Hide
C76H52O46
 2
1
IC50 = 2630.27 nM
   TI
   LI
   LO
   TS
2
Ki = 1460 nM
   TI
   LI
   LO
   TS
CP0137277
Abietic Acid
   Show/Hide
C20H30O2
 2
1
IC50 = 2691.53 nM
   TI
   LI
   LO
   TS
2
Ki = 1470 nM
   TI
   LI
   LO
   TS
CP0388301
[(2R,3R)-2-[1-[(2R,3R)-5,7-dihydroxy-3-(3,4,5-trihydroxybenzoyl)oxy-3,4-dihydro-2H-chromen-2-yl]-3,4,6-trihydroxy-5-oxobenzo[7]annulen-8-yl]-5,7-dihydroxy-3,4-dihydro-2H-chromen-3-yl] 3,4,5-trihydroxybenzoate
   Show/Hide
C43H32O20
 2
1
IC50 = 2754.23 nM
   TI
   LI
   LO
   TS
2
Ki = 1510 nM
   TI
   LI
   LO
   TS
CP0554481
(3S,6S,9S,12R,15S,18S,21S,24S,27R,30S,33S)-30-ethyl-33-[(E,1R,2R)-1-hydroxy-2-methylhex-4-enyl]-24-[(2S)-1-methoxypropan-2-yl]-1,4,7,10,12,15,19,25,27,28-decamethyl-6,9,18-tris(2-methylpropyl)-3,21-di(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone
   Show/Hide
C63H113N11O13
 1
1
IC50 = 2800 nM
   TI
   LI
   LO
   TS
CP0370401
(9beta,10alpha,11alpha,14beta,16alpha,17alpha)-9,21-dichloro-11-hydroxy-16-methyl-3,20-dioxopregna-1,4-dien-17-yl furan-2-carboxylate
   Show/Hide
C27H30Cl2O6
 2
1
IC50 = 2951.21 nM
   TI
   LI
   LO
   TS
2
Ki = 1620 nM
   TI
   LI
   LO
   TS
CP0391187
ERYTHROMYCIN ETHYLSUCCINATE
   Show/Hide
C43H75NO16
 2
1
IC50 = 3019.95 nM
   TI
   LI
   LO
   TS
2
Ki = 1670 nM
   TI
   LI
   LO
   TS
CP0877478
ANTHOTHECOL
   Show/Hide
C28H32O7
 2
1
IC50 = 3019.95 nM
   TI
   LI
   LO
   TS
2
Ki = 1650 nM
   TI
   LI
   LO
   TS
CP0133264
A-56268
   Show/Hide
C38H69NO13
 1
1
IC50 = 3090.3 nM
   TI
   LI
   LO
   TS
CP0038508
7-[8-formyl-1,6,7-trihydroxy-3-methyl-5-(propan-2-yl)naphthalen-2-yl]-2,3,8-trihydroxy-6-methyl-4-(propan-2-yl)naphthalene-1-carbaldehyde
   Show/Hide
C30H30O8
 2
1
IC50 = 3235.94 nM
   TI
   LI
   LO
   TS
2
Ki = 1780 nM
   TI
   LI
   LO
   TS
CP0054979
DIGOXIN
   Show/Hide
C41H64O14
 1
1
IC50 = 3235.94 nM
   TI
   LI
   LO
   TS
CP0433070
[(2R,3R,4S,5R)-3-[(2R,3R,4S,5R,6S)-5-[(2S,3R,4S,5R)-3,5-dihydroxy-4-[(2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxy-3,4-dihydroxy-6-methyloxan-2-yl]oxy-4,5-dihydroxyoxan-2-yl] (4aR,5R,6aR,6aS,6bR,8aR,10S,12aR,14bR)-5-hydroxy-2,2,6a,6b,9,9,12a-heptamethyl-10-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carboxylate
   Show/Hide
C58H94O25
 2
1
IC50 = 3311.31 nM
   TI
   LI
   LO
   TS
2
Ki = 1820 nM
   TI
   LI
   LO
   TS
CP0019370
Ketek
   Show/Hide
C43H65N5O10
 1
1
IC50 = 3467.37 nM
   TI
   LI
   LO
   TS
CP0109019
Conceptrol
   Show/Hide
C33H60O10
 2
1
IC50 = 3467.37 nM
   TI
   LI
   LO
   TS
2
Ki = 1920 nM
   TI
   LI
   LO
   TS
CP0423173
[(1R,4bR,5R,6aR,10aR,10bR,12aR)-1-(furan-3-yl)-4b,7,7,10a,12a-pentamethyl-3,8-dioxo-5,6,6a,9,10,10b,11,12-octahydro-1H-naphtho[2,1-f]isochromen-5-yl] acetate
   Show/Hide
C28H36O6
 2
1
IC50 = 3548.13 nM
   TI
   LI
   LO
   TS
2
Ki = 1940 nM
   TI
   LI
   LO
   TS
CP0461909
[(2R,3R)-5,7-dihydroxy-2-[3,4,5-trihydroxy-2-[2,3,4-trihydroxy-6-[(2R,3R)-3,5,7-trihydroxy-3,4-dihydro-2H-chromen-2-yl]phenyl]phenyl]-3,4-dihydro-2H-chromen-3-yl] 3,4,5-trihydroxybenzoate
   Show/Hide
C37H30O18
 2
1
IC50 = 3715.35 nM
   TI
   LI
   LO
   TS
2
Ki = 2050 nM
   TI
   LI
   LO
   TS
CP0074965
(-)-Epicatechin-3-gallate
   Show/Hide
C22H18O10
 2
1
IC50 = 3801.89 nM
   TI
   LI
   LO
   TS
2
Ki = 2070 nM
   TI
   LI
   LO
   TS
CP0272224
4-Epi-Hederagenin
   Show/Hide
C30H48O4
 2
1
IC50 = 3801.89 nM
   TI
   LI
   LO
   TS
2
Ki = 2110 nM
   TI
   LI
   LO
   TS
CP0086839
(3S,6S,9S,12R,15S,18S,21S,24S,27R,30S,33S)-30-ethyl-33-[(E,1R,2R)-1-hydroxy-2-methylhex-4-enyl]-1,4,7,10,12,15,19,25,27,28-decamethyl-6,9,18-tris(2-methylpropyl)-24-[(2R)-4-morpholin-4-ylbutan-2-yl]-3,21-di(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone
   Show/Hide
C67H120N12O13
 1
1
IC50 = 3900 nM
   TI
   LI
   LO
   TS
CP0014077
2,2-Dimethyl-5-(2,5-dimethylphenoxy)valeriansaeure
   Show/Hide
C15H22O3
 1
1
IC50 = 4073.8 nM
   TI
   LI
   LO
   TS
CP0433021
Acetyl Isogambogic Acid
   Show/Hide
C40H46O9
 2
1
IC50 = 4073.8 nM
   TI
   LI
   LO
   TS
2
Ki = 2240 nM
   TI
   LI
   LO
   TS
CP0281103
(3S,6S,9S,12R,15S,18S,21S,24S,27R,30S,33S)-30-ethyl-33-[(E,1R,2R)-1-hydroxy-2-methylhex-4-enyl]-1,4,7,10,12,15,19,25,27,28-decamethyl-6,9,18-tris(2-methylpropyl)-24-[(2R)-1-morpholin-4-ylpropan-2-yl]-3,21-di(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone
   Show/Hide
C66H118N12O13
 1
1
IC50 = 4300 nM
   TI
   LI
   LO
   TS
CP0423162
Erythromycin Estolate
   Show/Hide
C52H97NO18S
 2
1
IC50 = 4365.16 nM
   TI
   LI
   LO
   TS
2
Ki = 2410 nM
   TI
   LI
   LO
   TS
CP0281104
(3S,6S,9S,12R,15S,18S,21S,24S,27R,30S,33S)-30-ethyl-33-[(E,1R,2R)-1-hydroxy-2-methylhex-4-enyl]-24-[(2S)-1-[4-(2-methoxyethyl)piperazin-1-yl]propan-2-yl]-1,4,7,10,12,15,19,25,27,28-decamethyl-6,9,18-tris(2-methylpropyl)-3,21-di(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone
   Show/Hide
C69H125N13O13
 1
1
IC50 = 6100 nM
   TI
   LI
   LO
   TS
CP0645768
SID855643
   Show/Hide
C25H22O10
 2
1
IC50 = 6165.95 nM
   TI
   LI
   LO
   TS
2
Ki = 3370 nM
   TI
   LI
   LO
   TS
CP0429602
(1S,4bS,5R,6aS,10aS,10bS,12aS)-1-(furan-3-yl)-5-hydroxy-4b,7,7,10a,12a-pentamethyl-5,6,6a,9,10,10b,11,12-octahydro-1H-naphtho[2,1-f]isochromene-3,8-dione
   Show/Hide
C26H34O5
 2
1
IC50 = 6309.57 nM
   TI
   LI
   LO
   TS
2
Ki = 3440 nM
   TI
   LI
   LO
   TS
CP0119810
(3S,6S,9S,12R,15S,18S,21S,24S,27R,30S,33S)-30-ethyl-33-[(E,1R,2R)-1-hydroxy-2-methylhex-4-enyl]-1,4,7,10,12,15,19,25,27,28-decamethyl-6,9,18-tris(2-methylpropyl)-24-[(2S)-1-(2-morpholin-4-ylethoxy)propan-2-yl]-3,21-di(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone
   Show/Hide
C68H122N12O14
 1
1
IC50 = 6400 nM
   TI
   LI
   LO
   TS
CP0059405
CHOLIC ACID, METHYL ESTER
   Show/Hide
C25H42O5
 2
1
IC50 = 8317.64 nM
   TI
   LI
   LO
   TS
2
Ki = 4580 nM
   TI
   LI
   LO
   TS
CP0012708
5,7-dihydroxy-3-(4-hydroxyphenyl)-4H-chromen-4-one
   Show/Hide
C15H10O5
 2
1
IC50 = 9120.11 nM
   TI
   LI
   LO
   TS
2
Ki = 5000 nM
   TI
   LI
   LO
   TS
CP0423164
3-acetyl-11-keto-ursolic acid
   Show/Hide
C32H48O5
 1
1
IC50 = 11220.18 nM
   TI
   LI
   LO
   TS
CP0452575
(2R,3R,4S,5R)-2-azaniumyl-3,4,5,6-tetrahydroxyhexanoate
   Show/Hide
C6H13NO6
 1
1
IC50 = 11748.98 nM
   TI
   LI
   LO
   TS
CP0040077
(3beta)-3-hydroxyurs-12-en-28-oic acid
   Show/Hide
C30H48O3
 1
1
IC50 = 15848.93 nM
   TI
   LI
   LO
   TS
CP0423160
Oligomycin
   Show/Hide
C45H74O11
 1
1
Ki = 250 nM
   TI
   LI
   LO
   TS
CP0385369
[(1S,4bS,5R,8S,10aR,12aS)-5-acetyloxy-1-(furan-3-yl)-4b,7,7,10a,12a-pentamethyl-3-oxo-1,5,6,6a,8,9,10,10b,11,12-decahydronaphtho[2,1-f]isochromen-8-yl] acetate
   Show/Hide
C30H40O7
 1
1
Ki = 410 nM
   TI
   LI
   LO
   TS
CP0432848
methyl 2-[(1S,3S,5S,7S,8S,9R,12S,13S)-13-(furan-3-yl)-5-hydroxy-6,6,8,12-tetramethyl-17-methylidene-15-oxo-2,14-dioxatetracyclo[7.7.1.01,12.03,8]heptadecan-7-yl]acetate
   Show/Hide
C27H36O7
 1
1
Ki = 680 nM
   TI
   LI
   LO
   TS
CP0433020
Lorglumide Sodium
   Show/Hide
C22H31Cl2N2NaO4
 1
1
Ki = 2010 nM
   TI
   LI
   LO
   TS
CP0433031
Salinomycin Sodium
   Show/Hide
C42H69NaO11
 1
1
Ki = 2030 nM
   TI
   LI
   LO
   TS
CP0021823
(2R,3S,6S,7R,8R)-3-[(3-formamido-2-hydroxybenzoyl)amino]-8-hexyl-2,6-dimethyl-4,9-dioxo-1,5-dioxonan-7-yl 3-methylbutanoate
   Show/Hide
C28H40N2O9
 1
1
Ki = 2200 nM
   TI
   LI
   LO
   TS
CP0391197
[(1S,4bS,5R,8R,10S,10aR,12aR)-1-(furan-3-yl)-8,10-dihydroxy-4b,7,7,10a,12a-pentamethyl-3-oxo-1,5,6,6a,8,9,10,10b,11,12-decahydronaphtho[2,1-f]isochromen-5-yl] acetate
   Show/Hide
C28H38O7
 1
1
Ki = 2960 nM
   TI
   LI
   LO
   TS
Clinical Information about the Protein
Target 1 ( Liver organic anion transporter 1 (SLCO1B1) )
Target Type Literature-reported Target
Similar Protein(s) and Bioactivity Statistics
50% Identity
Protein ID Protein Name Protein Organism
PT03657 Solute carrier organic anion transporter family member 1B3 Homo sapiens, Human